EGFR NP_005219.2:P.S492R

Clinical trials for EGFR NP_005219.2:P.S492R explained in plain language.

Never miss a new study

Get alerted when new EGFR NP_005219.2:P.S492R trials appear

Sign up with your email to follow new studies for EGFR NP_005219.2:P.S492R, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo tested for Tough-to-Treat colorectal cancer

Disease control Ongoing

This study is testing whether two drugs, panitumumab and trametinib, can help control advanced colorectal cancer that has stopped responding to a previous, similar type of treatment. It involves 59 patients whose cancer has spread and who have specific genetic markers in their bl…

Matched conditions: EGFR NP_005219.2:P.S492R

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

EGFR NP_005219.2:P.S492R

Get alerted when new EGFR NP_005219.2:P.S492R trials appear

New drug combo tested for Tough-to-Treat colorectal cancer